Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Real Power, the Essence of Hardcore: GWM TANK 500’s Triumphant Return from the Middle East Expedition

    November 7, 2023

    PHBS Receives EQUIS Accreditation, Now Holding the "Triple Crown"

    November 7, 2023

    KKR to absorb Telecom Italia’s debt in €18.8 billion acquisition

    November 7, 2023
    Facebook X (Twitter) Instagram
    Jeddah PostJeddah Post
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Jeddah PostJeddah Post
    Home » Korea to receive 40 million COVID vaccines from Moderna
    Health

    Korea to receive 40 million COVID vaccines from Moderna

    March 4, 2021
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Telegram Email

    Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that the Company has entered into a supply agreement with the government of the Republic of Korea to provide 40 million doses of the Moderna COVID-19 Vaccine to support the government’s aim of providing vaccines to the public as soon as possible. Under the terms of the proposed agreement, deliveries would begin in May 2021.

    Korea to receive 40 million COVID vaccines from Moderna
    Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. 

    The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

    Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and BARDA. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit their website.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    FDA’s ban on tangy soda emulsifier BVO to echo global standards

    November 7, 2023

    How incorporating fiber-rich foods boosts holistic health

    November 2, 2023

    Aging gracefully with Dr. Peter Attia’s fitness strategy for lifelong vitality

    October 31, 2023

    Researchers highlight the extended health perks of insoluble fiber consumption

    October 28, 2023

    Discover the supplements and sauna sessions behind Dr. Attia’s sleep regimen

    October 28, 2023

    Researchers uncover pivotal proteins influencing severe asthma

    October 28, 2023
    Latest News

    KKR to absorb Telecom Italia’s debt in €18.8 billion acquisition

    November 7, 2023

    FDA’s ban on tangy soda emulsifier BVO to echo global standards

    November 7, 2023

    Apple breaks the mold with its MacBook Pro and M3 chip lineup

    November 3, 2023

    Japan rolls out $113 billion economic plan amid rising inflation.

    November 3, 2023

    $10.6 billion Halloween reveals the environmental toll of America’s spooky celebrations

    November 2, 2023

    Messi seals eighth Ballon d’Or title after World Cup heroics

    November 2, 2023

    Australia bows out, leaving Saudi Arabia unopposed for 2034 World Cup bid

    November 2, 2023

    How incorporating fiber-rich foods boosts holistic health

    November 2, 2023

    UK unveils plans for comprehensive crypto regulation by 2024

    October 31, 2023
    © 2021 Jeddah Post | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.